High-Throughput Screening Market Size, Share, Trends and Report 2023-2030

Market Overview
HTS is a drug discovery approach that allows for the automated testing of a large number of chemical and/or biological molecules for a specified biological target. High-throughput screening technologies, which employ robotics and automation to swiftly assess the biological or biochemical activity of a huge number of molecules, such as medications, are extensively used in the pharmaceutical sector.

HTS is an appropriate approach for analyzing pharmacological targets, such as agonists and antagonists for receptors (such as GPCRs) and enzymes. High-throughput screening, which employs robots, liquid handling equipment, data processing/control software, and sensitive detectors, enables a researcher to swiftly run millions of genetic, chemical, or pharmacological tests.

To Get a Free PDF Sample - https://www.datamintelligence.com/download-sample/high-throughput-screening-market

Market Growth Analysis
DataM Intelligence's latest proven results show that the "Global High-Throughput Screening (HTS) Market" is estimated to grow at a CAGR of 8% from 2023 to 2030.

Market Key Drivers
Increased funding and R&D budgets of multinational companies are driving worldwide clinical trials, resulting in market growth. HTS is finding new applications in stem cell research, toxicology, and other life science domains, which is increasing its popularity. HTS market development is further fueled by open innovation models and continuous technical advancements. As a result, these factors are projected to boost market growth.

Market Emerging Trend
The global healthcare industry is seeing an increase in demand for better diagnostic and treatment approaches due to the expanding incidence and prevalence of numerous diseases. To address this need, there is an increasing demand for new and better pharmaceuticals produced using modern technology. Drug research and discovery, on the other hand, is a difficult and time-consuming process that usually takes 10-15 years and costs billions of dollars. High throughput screening (HTS) has emerged as a favoured approach among researchers in this field. HTS contributes to a shorter drug development schedule by screening hundreds of thousands of samples per day.

HTS employs various detection methods, such as fluorescence polarization (FP), fluorescence intensity distribution analysis (FIDA), and biochemical tests, as well as modern technological advances, such as downsizing and the use of artificial intelligence. These developments help to shorten the time necessary for medication development.

Moreover, the rising number of clinical trials results in a greater number of therapeutic candidates for screening, propelling the usage of HTS in the drug development process even further. As a consequence, all of these factors are expected to drive the high throughput screening market throughout the forecast period.

Segment Analysis
The global high-throughput screening (HTS) market is segmented by technology, application, end-user, and region.

By Technology
Ultra-high-throughput Screening
Cell-based Assays
Lab-on-a-chip
Label-free Technology
Others

By Application
Target Identification
Primary Screening
Toxicology
Others

By End-User
Pharmaceutical and Biotechnology
Academia and Research Institutes
Others

By Region
North America
Europe
South America
Asia Pacific
Middle East, and Africa

Based on End User, the Pharmaceutical and Biotechnology Segment is Expected to Have Highest Market Share

The pharmaceutical and biotechnology firms segment was estimated to be worth roughly USD 16.7 billion in 2022. This is largely due to the increased use of HTS technologies in the drug development process by pharmaceutical firms worldwide. The need for precise, rapid, and faster screening of target molecules during the drug development process, as well as the adoption of the uHTS method for screening large numbers of chemical and biomarker libraries generated during the research phase, is expected to drive the segment forward.
Furthermore, an increase in R&D investment by major pharma and biotech businesses throughout the globe is expected to contribute to industry development.

To Get More Insights - https://www.datamintelligence.com/research-report/high-throughput-screening-market

Recent News
In February 2023, Agilent Technologies, Inc. launched the on-deck thermal cycler, which interfaces with the Agilent Bravo NGS automated liquid handling platform.
PerkinElmer Inc. released the Multimode Plate Reader in February 2023 for high-throughput screening (HTS) applications and to enhance drug development efforts.

Geographical Share
North America Led the Global High Throughput Screening (HTS) Market
North America dominated the global high throughput screening market, which is predicted to increase at a 7.7% CAGR by 2032. The rapid expansion of the market is attributed to a variety of causes, including a high illness burden rate, technical improvements, higher R&D investment, and industrial cooperation among major companies, among others.

Moreover, the existence of important market participants, a rise in the incidence and prevalence of chronic illnesses, and a rising trend of open innovation models are expected to boost market growth.

Competitive Landscape
The prominent players contributing to the global high throughput screening (HTS) market growth include Agilent Technologies Inc., Axxam SpA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Merck KGaA, PerkinElmer Inc., Tecan Group Ltd, Hamilton Company, Aurora Biomed, and Thermo Fisher Scientific Inc.

Trending Topics
Foveal Atrophy Market - https://www.datamintelligence.com/research-report/foveal-atrophy-market
Meningitis Vaccines Market - https://www.datamintelligence.com/research-report/meningitis-vaccines-market
Cystic Fibrosis Market - https://www.datamintelligence.com/research-report/cystic-fibrosis-market
Oligonucleotide Synthesis Market - https://www.datamintelligence.com/research-report/oligonucleotide-synthesis-market
Myomectomy Market - https://www.datamintelligence.com/research-report/myomectomy-market

Media Contact
Company Name: DataM Intelligence
Contact Person: Sai.K
Email: Send Email
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com/

About DataM Intelligence
DataM Intelligence 4Market Research is a Market Research firm that provides end-to-end business solutions to organizations from Research to Consulting. We at DataM Intelligence leverage our top trademark trends, insights, and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of Syndicate Reports & and; Customized Reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries, catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.